// App-Quantinova.ai

2271 : Tebentafusp recognition of melanoma cells is restricted by HLA-A0201 presentation of a gp100 peptide

Researchers

Presenter

  • David Cole

Principal Investigators

  • Ross Robinson

  • Velupillai Srikannathasan

  • Vijay Karuppiah

  • Stephen Harper

  • Charlotte Coles

  • Viren Patel

  • Anitha Jevanthan

  • Jane Harper

  • David Berman

  • Alex Powesland

Medical Centers

  • Immunocore, Ltd, Abingdon, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • Major Histocompatibility Complex, Class I, A

  • T-cell receptor

Drug/Treatment

  • GP100

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved